Advancing Reperfusion Therapy for Ischemic Stroke: Direct Transfer to Angiography Suite for Patients With Suspected Large Vessel Occlusion

Exclusion Criteria

• •Refusal of endovascular treatment；
• •Allergy to contrast agents;
• •Clinical symptoms or signs suggestive of intracranial hemorrhage (e.g., severe headache, seizures, or signs of increased intracranial pressure);
• •Transferred patients (e.g., from centers without thrombectomy capability);
• •Seizure at stroke onset, postictal paralysis, or inability or unwillingness to cooperate due to epilepsy or other neurological or psychiatric disorders;
• •Clinically unstable conditions requiring urgent life-support treatment;
• •Other standard contraindications to endovascular treatment;
• •Any terminal illness such that the patient would not be expected to survive more than 1 year;
• •Pregnant women, nursing mothers, or women with a positive pregnancy test at admission;
• •Unlikely to adhere to the trial protocol or follow-up;
• •Any condition that, in the judgment of the investigator could impose hazards to the patient if study therapy is initiated or affect the participation of the patient in the study;
• •Participation in other interventional clinical trials within the previous 3 months.